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The solid-phase synthesis and characterization of a series of accomplished by means of diisopropylcarbodiimide (DIC)/
hydroxyazabenzotriazole (HOAt). Coupling between aminopeptides (4–15) containing reverse-turn mimetic bicyclic
lactams is reported. The bicyclic lactams (1a, 1b) possess acids and the mimics was performed with the potent
Carpino’s reagent O-(7-azabenzotriazol-1-yl)-N,N,N9,N9-high structural similarity to the two central residues of a â-
turn. Amino acid conjugates of these bicyclic lactams were tetramethyluronium hexafluorophosphate (HATU). The final
compounds were cleaved from the resin and obtained as N-synthesized on solid supports following a 9-fluor-
enylmethoxycarbonyl (FMOC) protection strategy on Wang- acetylated methyl esters or benzyl amides.
Merrifield resin. Coupling between amino acids was
turn mimetic compound enforcing chain reversal, [4] or byIntroduction
attaching peptide chains to a molecular scaffold possessing
The synthesis of artificial peptides containing pre-deter- the required geometric parameters to induce a â-sheet. [5] [6]
mined structural motifs is one of the most interesting and Several â-turn mimics and â-sheet nucleators have been de-
promising areas for the construction of bioactive molecules. signed, synthesized, and tested for nucleation of antiparallel
The typical structural motifs of natural proteins such as α- â-sheets, [4] [5] while only a few have been designed for the
helix, â-sheet, and reverse-turn, provide a clear basis for the induction of parallel â-sheets.[5x,6]
design of synthetic peptidomimetics. â-Turns, with their On the other hand, the physical basis for the â-sheet
ten-membered-ring H-bond, are an important motif in forming propensity of the various amino acids is not clearly
natural proteins for folding and generating compact struc- established. In 1993 and 1994, three teams of researchers
tures, and their structural mimics have been extensively in- reported studies on the propensities of different amino acids
vestigated. [1] ª-Turns, with their seven-membered-ring H- to form antiparallel â-sheets.[7a27d] These studies involved
bond, have also attracted significant attention as turn ele- systematically varying amino acids within small â-sheet-
ments that may induce a more compact and rigid structure containing proteins and quantifying the effects of the mu-
in proteins compared to â-turns. [2] However, among the tations upon the thermodynamic stabilities of the proteins.
common protein secondary structures, the â-sheet is the Recently, Nowick and co-workers reported on the propen-
least well-understood, despite the fact that many biological sities of four different amino acids to form parallel â-sheets,
processes are connected with the creation of a â-sheet struc- and found that leucine and valine are relatively good, ala-
ture in peptides and proteins. The synthesis of small, sol- nine is moderate, while glycine is poor. [7e] Although other
uble model compounds represents an area of intense re- contributions such as conformational entropy, steric fac-
search with the aim of improving the understanding of tors, and hydrophobic interactions are also likely to be in-
these important secondary structures. To investigate the volved, the influence of the amino acid side-chains on elec-
thermodynamic and kinetic features of â-sheets, model sys- trostatic interactions and hydrogen bonding appears to be
tems have been devised that enhance the probability of â- the most important factor in determining â-sheet forming
sheet formation by using designed templates that bring two propensities.
polypeptide chains into close proximity. A â-sheet structure Recently, the design and synthesis of two bicyclic lactams
can be induced in different ways: with the aid of a template (1a, b) (Figure 1) possessing high structural similarity to the
like Kemp’s diacylaminoepindolidione derivative, [3] of a two central residues of a â-turn was reported by researchers
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Figure 2. General structure of the constrained N-acetylated tripeptide, tetrapeptide, and hexapeptide mimics
Figure 3. Tripeptide mimics incorporating both (5,7)- and (5,6)-
bicyclic lactams
in Milan.[8a28c] Peptides incorporating these lactams would
be capable of adopting intramolecular hydrogen-bonded
conformations. The conformational preferences of the re-
sulting constrained peptides would offer the opportunity of
investigating in detail the secondary structures (ª- vs. â-
turns) and the propensity to adopt an antiparallel â-sheet
conformation (â-hairpin).
In this paper, we report the solid-phase synthesis of a
number of peptides containing reverse-turn mimetic bicyclic
lactams (1a, b). The general structures of these constrained
N-acetylated tripeptide, tetrapeptide, and hexapeptide mim-
ics, with methyl ester or benzyl amide functions as carboxy
terminal groups, are shown in Figure 2. In order to study
the influence of the bicyclic lactam, of the amino acid se-
quence, and of the type of carboxy terminal group on the
preferred folding pattern, the constrained peptides 4215
were prepared (Figures 3, 4, and 5). Among the proteinog- Figure 4. N-Acetylated tetrapeptide mimics incorporating both the
enic amino acids, Val and Ala were specifically chosen be- (5,7)- and the (5,6)-bicyclic lactams
cause of their propensity to appear in â-sheet regions. [7]
Other natural amino acids such as Phe, Gly, Met, and Cys
were also selected. Investigation of the conformational pref-
erences of the peptide derivatives by the use of NMR spec-
troscopy, IR spectroscopy, and computational methods is
discussed in the accompanying paper. [8d]
Results and Discussion
The synthesis and structural characterization of bicyclic
lactams 1a and 1b has been reported previously.[8a28c]
Amino acid conjugates of these bicyclic lactams were syn-
thesized on solid-phase supports following a 9-fluorenyl-
methoxycarbonyl (FMOC) protection strategy on Wang2-
Merrifield resin. [9] For this purpose, the free amino group
in compounds 1a and 1b was first protected with the
FMOC group employing FMOC2O2succinimide (FMO-
C2O2NSu) with 2,6-lutidine as base. Subsequent tri-
fluoroacetic acid treatment afforded the N-FMOC2- Figure 5. N-Acetylated hexapeptide mimics incorporating both the
(5,7)- and the (5,6)-bicyclic lactams[bicyclic lactam]2OH compounds (3a, b, 90% overall yield
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O2resin (or H2AA22AA12O2resin) was used, and the
couplings were performed with the potent Carpino9s
reagent O-(7-azabenzotriazol-1-yl)-N,N,N9,N9-tetramethyl-
uronium hexafluorophosphate (HATU).[14] This reagent,
often used in the presence of HOAt, is highly efficient for
difficult couplings of hindered substrates and has been ex-
tensively used for coupling N-methyl amino acids. [15] It re-
quires the presence of a base: diisopropylethylamine (DI-
PEA) is usually employed, but in long coupling cycles epi-
Scheme 1. Synthesis of the N-FMOC2[bicyclic lactam]2OH com-
merization as well as FMOC deprotection have been re-pounds 3a and 3b starting from H2[bicyclic lactam]2OtBu com-
pounds 1a and 1b; a: FMOC2ONSu (1.5 equiv.), 2,6-lutidine (1.5 ported, and 2,4,6-collidine has been proposed as a better
equiv.), THF, 0°C, 6.7 h; b: TFA, DCM, 1.5 h, room temp. alternative. [14b] After extensive optimization, we found that
the best conditions for attachment of peptidomimetics 3 to
the growing peptide chain were HATU/HOAt/2,4,6-collid-for the two steps) ready for use in solid-phase chemistry
ine/N-FMOC2[bicyclic lactam]2OH/H2AA22AA12O2(Scheme 1).
resin (or H2AA22O2resin) in a ratio 2:2:2:1:1.2 for 15 hA representative sequence for the solid-phase synthesis of
at room temperature.the constrained peptides is outlined in Scheme 2. N-FMOC
2glycine was attached to the Wang2Merrifield resin by Once the FMOC-peptidomimetic bicyclic lactam had
been inserted into the peptide chain, excess free NH2 groupsmeans of the diisopropylcarbodiimide (DIC)/1-hydroxy-
benzotriazole (HOBt)/4-dimethylaminopyridine (DMAP) were capped by means of acetylimidazole, which proved to
be the most effective capping method. After deprotectionprotocol, [10] while attachment of other N-FMOC-amino
acids was accomplished following the Sieber procedure, [11] of the FMOC group, incorporation of the subsequent am-
ino acid on the H2[bicyclic lactam]2AA22AA12O2resinwhich employs 2,6-dichlorobenzoyl chloride and pyridine
in dichloromethane. The final loadings of these resins were {or H2[bicyclic lactam]2AA22O2resin} (1 equiv.) was ac-
complished with HATU/HOAt/2,4,6-collidine/N-FMOC2established using the quantitative picric acid test [12] and the
possibly present hydroxy groups (not reacted) were capped AA32OH (4 equiv.:4 equiv.:4 equiv.:4 equiv.). At this stage,
the use of a double amount of 2,4,6-collidine (8 equiv.) ledwith Ac2O or PhCOCl. Deprotection of the amino groups
was effected with a 20% piperidine solution in dimethylfor- to a mixture of compounds, presumably due to partial de-
protection of the FMOC group of the newly attached N-mamide. Coupling between amino acids was performed
with DIC/hydroxyazabenzotriazole (HOAt) and that the re- FMOC-amino acid, resulting in double incorporation of
the same amino acid. When DIPEA was used instead ofaction had reached completion was verified by performing
a TNBS test. [13] 2,4,6-collidine, some epimerization was observed. The
coupling efficiency was checked by performing a TNBSFor incorporation of the bicyclic lactams into the grow-
ing peptide chains, a 1.0:1.2 ratio lactam 3a,b/H2AA22 test, [13] which proved effective only in the case of the amino
Scheme 2. General scheme for the solid-phase synthesis of the constrained peptides 4215; a: N-FMOC2AA12OH (2 equiv.), Py (3.3
equiv.), 2,6-dichlorobenzoyl chloride (2 equiv.), DMF, 20 h; followed by PhCOCl (3.5 equiv.), Py (5 equiv.), DCM, 2 h [alternatively: N-
FMOC2Gly2OH (3 equiv.), HOBt (3 equiv.), DIC (3 equiv.), DMAP (cat.), DMF, 16 h; followed by Ac2O (2 equiv.), DMAP (1 equiv.),
DCM, 2 h]; b: 20% piperidine/DMF followed by N-FMOC2AA22OH (3 equiv.), DIC (3 equiv.), HOAt (3 equiv.), DCM/DMF, 2.5 h;
c: 20% piperidine/DMF followed by N-FMOC2[bicyclic lactam]2OH (1 equiv.), HATU (2 equiv.), HOAt (2 equiv.), 2,4,6-collidine (2
equiv.), DCM/DMF, 15 h; d: acetyl imidazole (10 equiv.), DCM, 2 h; e: 20% piperidine/DMF followed by N-FMOC2AA32OH (4
equiv.), HATU (4 equiv.), HOAt (4 equiv.), 2,4,6-collidine (4 equiv.), DCM/DMF, 15 h; f: 20% piperidine/DMF followed by N-
FMOC2AA42OH (3 equiv.), DIC (3 equiv.), HOAt (3 equiv.), DCM/DMF, 2.5 h; g: 20% piperidine/DMF followed by acetyl imidazole
(10 equiv.), DCM, 2 h.
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Scheme 3. General scheme for the cleavage of the constrained peptides from the Wang2Merrifield resin; a: TFA/H2O, 95:5; b: BnNH2
(1 equiv.), HATU (2 equiv.), 2,4,6-collidine (2 equiv.), DMF; c: CH2N2, AcOEt/Et2O; d: MeOH/TEA/DMF, 50°C, 24 h.
group of the (5,7)-bicyclic lactam (type a), showing that 1 1b. This methodology renders these bicyclic lactams par-
ticularly attractive as building blocks for combinatorialcycle was sufficient for quantitative coupling. The TNBS
test failed with the (5,6)-bicyclic lactam (type b) because of chemistry. On the other hand, the conformational prefer-
ences of the synthesized peptides offer the possibility of in-the reduced reactivity of the more hindered amino group.
In this case, after extensive optimization of the conditions, vestigating the secondary structures (â-turns, ª-turns and â-
hairpins). Investigation of the conformational preferencesit was established (by cleavage from the resin) that two
cycles were required for quantitative coupling of the N- of the peptide derivatives using NMR spectroscopy, IR
spectroscopy, and computational methods is discussed inFMOC2amino acid to the type-b lactam. After inco-
rporation of the final N-FMOC2amino acid, the resulting the accompanying paper. [8d] Further work on the prep-
aration of combinatorial libraries of constrained peptides isconstrained peptides were subjected to 20% piperidine/
DMF treatment to deprotect the FMOC group, and sub- in progress and will be reported in due course.
sequent acetylation with acetyl imidazole in dichlorometh-
ane to give the desired N-acetylated resin-bound peptides.
Attempts to directly acetylate the amino group of the (5,6)- Experimental Sectionbicyclic lactam with acetylimidazole (synthesis of com-
General: Wang2Merrifield resin was purchased from Fluka andpound 5b) were unsuccessful. In this case, acetylation was
Novabiochem (1002200 mesh, 0.620.8 mmol/g). All products weresuccessfully achieved with Ac2O/TEA in dichloromethane.
purified by flash chromatography using 2302400 mesh silica gelFinal cleavage of the peptides from the resin was effected
(Merck). TLC analyses were performed with 0.25 mm 60 F254 silicaby acid treatment (TFA/H2O, 95:5) with subsequent esterifi- plates (Merck). All the solvents used for the solid-phase synthesis
cation of the resulting acids with diazomethane, or by direct were of HPLC quality or Analytical Reagent grade. Dichlorometh-
synthesis of the methyl esters using a TEA/MeOH/DMF ane (DCM), diisopropylethylamine (DIPEA), triethylamine (TEA),
solution at 50°C.[5w] For the preparation of the benzyl am- N,N-dimethylformamide (DMF), and methanol (MeOH) were dis-
ides, after the acidic cleavage (TFA/H2O) the resulting acids tilled from CaH2 under nitrogen. 2,4,6-Collidine and 2,6-lutidine
were coupled with benzylamine in the presence of HATU were purchased from Fluka and used without further purification.
Organic extracts were dried with Na2SO4. All solid-phase reactionsand 2,4,6-collidine. For peptide derivatives containing
were carried out on a wrist shaker (Lab-Line multi-wrist shaker).methionine (compounds 7a and 7b) a TFA/H2O/EtSMe
2 NMR: Bruker AC-200, Bruker AC-300. 2 Optical rotations:solution (95:5:1) was used for the acidic cleavage, and after
Perkin-Elmer 141 polarimeter. 2 UV: Perkin-Elmer Lambda 6 UV/the usual work-up Ph3P was added in order to prevent Vis spectrophotometer. 2 Elemental analyses are available as Sup-methionine oxidation. The desired final compounds (overall
porting Information on the www under http://www.wiley.vch.de/
yields 20250%) were easily separated from small amounts home/eurjoc or from the author.
of mono- and dipeptides (AcAA2AA1R or AcAA2R; R 5
Preparation of N-FMOC2[bicyclic lactam]2OtBu (2)OMe, NHBn) by flash chromatography on silica gel
(Scheme 3). General Procedure: FMOC2ONSu (1.5 equiv.) and 2,6-lutidine
(1.5 equiv.) were added to a solution of H2[bicyclic lactam]2OtBu
(1) (0.17 mmol) in THF (1.7 ml) at 0°C, and the resulting mixture
was stirred at this temperature for 627 h. Consumption of theConclusions
starting material was monitored by TLC. The solvent was then eva-
We have developed a solid-phase synthesis of the peptide porated under reduced pressure without heating and the resulting
residue was purified by flash chromatography on silica gel.mimics 4215 incorporating the reverse-turn mimics 1a and
Eur. J. Org. Chem. 1999, 3792388382
Solid-Phase Synthesis of Peptides Containing Reverse-Turn Mimetic Bicyclic Lactams FULL PAPER
(3S,7S,10S)-1-Aza-10-tert-butyloxycarbonyl-3-(99-fluorenylmeth- equiv., 276 ìL), and then 2,6-dichlorobenzoyl chloride (2 equiv.,
297 ìL) were added, and the suspension was shaken for 20 h atoxycarbonylamino)-2-oxobicyclo[5,3,0]decane, N-FMOC2[(5,7)-bi-
cyclic lactam]2OtBu (2a): The general procedure was followed room temperature. It was then washed with DMF (5 3 10 mL) and
DCM (5 3 10 mL), and dried in vacuo. The final loading wasusing 1a and the crude reaction mixture was purified by flash col-
umn chromatography on silica gel (acetone/n-hexane, 25:75, Rf 5 determined by performing a quantitative picric acid test (found
loadings: 0.70 mmol/g for N-FMOC2Phe2OH, 0.62 mmol/g for0.35). White solid, low melting point; yield 90%. 2 [α]D 5 227.3
(c 5 0.56, CHCl3). 2 1H NMR (300 MHz, CDCl3, 300 K): ä 5 N-FMOC2Val2OH and 0.64 mmol/g for N-FMOC2Met2OH).
Capping was performed with benzoyl chloride (3.5 equiv., 420 ìL)7.75 (d, 2 H, J 5 7.5 Hz, aromatic H), 7.60 (d, 2 H, J 5 7.5 Hz,
aromatic H), 7.4027.23 (m, 4 H, aromatic H), 6.28 (d, 1 H, J 5 and pyridine (5 equiv., 417 ìL) in DCM (13 mL) for 2 h. The
solution was drained, the resin was rinsed with DCM (5 3 10 mL),7.5 Hz, NHFMOC), 4.52 (t, 1 H, J 5 7.5 Hz, CHCO2tBu),
4.3824.18 (m, 4 H, CHNHFMOC, NHCO2CH2, and dried in vacuo.
NHCO2CH2CH), 3.8823.75 (m, 1 H, CHNCO), 2.2921.40 (m, 10 General Procedure for the Preparation of the Resin-Bound Peptide
H, CH2), 1.49 (s, 9 H, tBu). 2 13C NMR (50 MHz, CDCl3, 300 Mimics
K): ä 5 170.9, 170.7, 155.4, 143.9, 141.2, 127.5, 126.9, 125.1, 119.8,
General Procedure 1: H2[Bicyclic lactam]2Gly2O2Wang-Merri-81.4, 66.8, 61.3, 59.1, 54.7, 47.1, 34.2, 32.8, 31.5, 27.9, 27.6.
field Resin: A 5-mL solid-phase reaction vessel was charged with N-(3S,6S,9S)-1-Aza-3-benzyl-9-tert-butyloxycarbonyl-3-(99-fluorenyl-
FMOC2Gly2O2Wang-Merrifield resin (0.62 mmol/g, 1.2 equiv.),methoxycarbonylamino)-2-oxobicyclo[4,3,0]nonane, N-FMOC2
which was treated with a 20% piperidine/DMF solution (2.7 mL,[(5,6)-bicyclic lactam]2OtBu (2b): The general procedure was fol-
1 3 3 min, 2 3 17 min). The solution was drained and the resinlowed using 1b and the resulting residue was purified by flash chro-
was washed with DMF (3 3 2 mL), MeOH (2 3 2 mL), and DCMmatography on silica gel (ethyl acetate/n-hexane, 30:70, Rf 5 0.33). (3 3 2 mL). Then, HATU (2 equiv.), HOAt (2 equiv.), the corre-At room temperature, the 1H-NMR spectrum in CDCl3 showed sponding N-FMOC2[bicyclic lactam]2OH (1 equiv.), DCM/DMFthe presence of two conformational isomers. A variable-tempera-
(1:3, 2.4 mL/0.1 mmol of amino groups), and 2,4,6-collidine (2ture NMR study was carried out, in which the two rotamers be-
equiv.) were successively added and the resulting mixture wascame resolved at 323K ([D6]benzene). White solid, low melting shaken for 15 h at room temperature. The solution was drainedpoint; yield 90%. 2 [α]D 5 155.0 (c 5 0.5, MeOH). 2 1H NMR and the resin was washed with DMF (3 3 2 mL), MeOH (2 3 2(300 MHz, [D6]benzene, 323 K): ä 5 7.61 (d, 2 H, J 5 7.1 Hz, mL), and DCM (3 3 2 mL). The unreacted amino groups possiblyaromatic H), 7.52 (t, 2 H, J 5 7.1 Hz, aromatic H), 7.2927.02 (m,
present were capped by treatment with a 0.33  solution (10 equiv.)9 H, aromatic H), 6.13 (s, 1 H, NHFMOC), 4.5024.30 (m, 2 H,
of acetylimidazole in DCM for 2 h. The solution was drained andNHCO2CH2), 4.28 (d, 1 H, J 5 7.1 Hz, CHCO2tBu), 4.12 (t, 1 H, the resin was washed with DCM (5 3 2 mL). At this stage, a TNBSJ 5 7.1 Hz, NHCO2CH2CH), 3.51 (d, 1 H, J 5 14.2 Hz, HCHPh), test [13,17] indicated that the capping was complete. The FMOC3.31 (d, 1 H, J 5 14.2 Hz, HCHPh), 2.88 (br. s, 1 H, CHNCO),
group was deprotected following the same procedure as described2.6822.53 (m, 1 H, CH), 2.1222.03 (m, 1 H, CH), 1.7021.28 (m,
above. The resulting resin was dried in vacuo and the title com-6 H, CH2), 1.42 (s, 9 H, tBu). 2 13C NMR (75 MHz, [D6]benzene, pounds were cleaved from it following one of the cleavage pro-323 K): ä 5 171.5, 170.6, 155.7, 145.4, 142.5, 137.8, 131.9, 129.2,
cedures outlined below.129.0, 128.7, 128.5, 128.2, 128.0, 127.7, 126.3, 120.8, 81.9, 67.5,
General Procedure 2: Ac2[Bicyclic lactam]2Gly2O2Wang-Merri-61.3, 59.6, 48.6, 43.9, 32.5, 31.1, 29.9, 28.8, 27.6.
field Resin: A 5-mL solid-phase reaction vessel was charged with N-General Procedure for the Preparation of N-FMOC2[bicyclic lac-
FMOC2Gly2O2Wang-Merrifield resin (0.62 mmol/g, 1.2 equiv.),tam]2OH (3): A solution of the starting N-FMOC2[bicyclic lactam]
which was treated with a 20% piperidine/DMF solution (2.7 mL,2OtBu (2) (0.14 mmol) in trifluoroacetic acid (1.08 mL) and di-
1 3 3 min, 2 3 17 min). The solution was drained and the resinchloromethane (1.08 mL) was stirred at room temperature for 1.5
was washed with DMF (3 3 2 mL), MeOH (2 3 2 mL), and DCMh. The solvents were then evaporated under reduced pressure and
(3 3 2 mL). Then, HATU (2 equiv.), HOAt (2 equiv.), the corre-the crude residue thus obtained was used directly in the following
sponding N-FMOC2[bicyclic lactam]2OH (1 equiv.), DCM/DMFsteps.
(1:3, 2.4 mL/0.1 mmol of amino groups), and 2,4,6-collidine (2
General Procedure for N-FMOC2Amino Acid Loading onto Wang equiv.) were successively added and the mixture was shaken for 15
2Merrifield Resin h at room temperature. The solution was drained and the resin was
washed with DMF (3 3 2 mL), MeOH (2 3 2 mL), and DCM (3General Method A: Loading of N-FMOC2Gly2OH: [10] A mixture
3 2 mL). The unreacted amino groups possibly present wereof N-FMOC2Gly2OH (0.84 mmol), HOBt (0.84 mmol), DIC
capped by treatment with a 0.33  solution (10 equiv.) of acetylimi-(0.84 mmol), and DMAP (0.08 mmol) in DMF (3 mL) was added
dazole in DCM for 2 h. The solution was drained and the resinto a suspension of Wang2Merrifield resin (400 mg, 0.620.8 mmol/
was rinsed with DCM (5 3 2 mL). At this stage, a TNBS testg, 0.28 mmol) in DMF (1.4 mL). After shaking for 16 h at room
indicated that the capping was complete. The FMOC group wastemperature, the resin was washed with DMF (5 3 5 mL) and
then deprotected following the same procedure as described aboveDCM (5 3 5 mL). A quantitative picric acid test [12,16] indicated a
and the resulting free amino groups were acetylated using aceticloading of 0.62 mmol/g. Then, acetic anhydride (2 equiv., 0.56
anhydride (10 equiv.) and TEA (10 equiv.) in DCM (2.7 mL) for 2mmol, 53 ìL), DMAP (1 equiv., 0.28 mmol, 10 mg) and DCM (4
h. After the usual washings with DCM (5 3 2 mL), the resin wasmL) were added and the resulting mixture was shaken for a further
dried in vacuo and the resulting compounds were cleaved from it2 h at room temperature. The solution was drained, the resin was
following one of the cleavage procedures outlined below.washed with DMF (5 3 5 mL) and DCM (5 3 5 mL), and dried
in vacuo. General Procedure 3: Ac2AA32[Bicyclic lactam]2AA22O2Wang-
Merrifield Resin: A solid-phase reaction vessel was charged with N-General Method B: Loading of Other N-FMOC2Amino Acids: [11]
1.5 g of Wang2Merrifield resin (0.620.8 mmol/g, 1.05 mmol) and FMOC2AA22O2Wang-Merrifield resin (1.2 equiv.), which was
treated with a 20% piperidine/DMF solution (2 mL/100 mg of re-the corresponding N-FMOC2amino acid (2 equiv.) were shaken in
DMF (13 mL) at room temperature for 15 min. Pyridine (3.3 sin, 1 3 3 min., 2 3 17 min.). The solution was drained and the
Eur. J. Org. Chem. 1999, 3792388 383
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resin was washed with DMF (3 3 2 mL), MeOH (2 3 2 mL), and were successively added and the mixture was shaken at room tem-
perature for 15 h. The solution was drained and the resin was rinsedDCM (3 3 2 mL). Then, HATU (2 equiv.), HOAt (2 equiv.), the
corresponding N-FMOC2[bicyclic lactam]2OH (1 equiv.), DCM/ with DMF (3 3 2 mL), MeOH (2 3 2 mL), and DCM (3 3 2 mL).
The success of the coupling reaction was assessed by performing aDMF (1:3, 2.4 mL/0.1 mmol of amino groups), and 2,4,6-collidine
(2 equiv.) were successively added and the mixture was shaken for TNBS test for the (5,7)-bicyclic lactam derivatives (a series), which
showed that 1 cycle was sufficient for quantitative coupling. In the15 h at room temperature. The solution was drained and the resin
was washed with DMF (3 3 2 mL), MeOH (2 3 2 mL), and DCM case of the (5,6)-bicyclic lactam (b series), this test failed and two
coupling cycles were run in all cases. The FMOC group was again(3 3 2 mL). The unreacted amino groups possibly present were
capped by treatment with a 0.33  solution of acetylimidazole (10 deprotected and a solution of N-FMOC2AA42OH (3 equiv.) in
DCM/DMF (4:1, 0.062 ), preactivated with DIC (3 equiv.) andequiv.) in DCM for 2 h. The solution was drained and washed
with DCM (5 3 2 mL). The capping efficiency was assessed by HOAt (3 equiv.) in the same manner as described above, was then
added and the suspension was shaken for 2.5 h at room tempera-performing a TNBS test and in the event of incomplete capping a
second cycle was carried out. A solution of 20% piperidine in DMF ture. The solution was then drained and the resin was rinsed with
DMF (3 3 2 mL) and DCM (3 3 2 mL). In all cases, TNBS testswas then used to deprotect the FMOC group following the same
procedure as described above. N-FMOC2AA32OH (4 equiv.), showed that 1 coupling cycle was sufficient for completion of the
reaction. The FMOC group was then deprotected and the resultingHATU (4 equiv.), HOAt (4 equiv.), DCM/DMF (1:3, 4.38 mL/0.1
mmol of amino groups), and 2,4,6-collidine (4 equiv.) were success- free amino groups were acetylated with a solution of acetylimid-
azole in DCM (10 equiv., 0.33 ) (2 h cycles). The resin was washedively added and the mixture was shaken at room temperature for
15 h. The solution was drained and the resin was rinsed with DMF with DCM (5 3 2 mL) and the acetylation was assessed by per-
forming a TNBS test. The title compounds were cleaved from the(3 3 2 mL), MeOH (2 3 2 mL), and DCM (3 3 2 mL). This
coupling reaction was followed by a TNBS test for the (5,7)-bicyclic resin following one of the cleavage procedures outlined below.
lactam derivatives (a series), which showed that 1 cycle was suf-
Cleavage of the Peptide Mimics from the Resinficient for quantitative coupling. In the case of the (5,6)-bicyclic
lactam (b series), this test failed and two coupling cycles were run Cleavage as Methyl Esters. 2 General Procedure A: Acidic Cleav-
in all cases. The FMOC group was again deprotected and a solu- age: The appropriate resin was treated with TFA/H2O solutiontion of acetylimidazole in DCM (10 equiv., 0.33 ) was used to (95:5, v/v) (5.2 mL/0.1 mmol, 1 3 3 min, 1 3 2 h, and 3 3 5 min).
acetylate the amino group (2 h cycles). The resin was rinsed with The solutions were drained, combined, and concentrated under re-
DCM (5 3 2 mL) and the acetylation was assessed by performing duced pressure to yield a residue, which was subsequently dissolved
a TNBS test. The title compounds were cleaved from the resin fol- in AcOEt/Et2O, 3:1 (3 mL). To this solution, cooled to 0°C, alowing one of the cleavage procedures outlined below. freshly prepared and distilled solution of CH2N2 in Et2O contain-
ing 223 mmol was added dropwise. After stirring for 10 min atGeneral Procedure 4: Ac2AA42AA32[Bicyclic lactam]2AA22 0°C and for 1 h at room temperature, the excess diazomethane wasAA12O2Wang-Merrifield Resin: A solid-phase reaction vessel was destroyed by the addition of a few drops of glacial acetic acid.charged with N-FMOC2AA12O2Wang-Merrifield resin (1.2 Evaporation of the solvents under reduced pressure afforded a resi-equiv.), which was treated with a 20% piperidine/DMF solution [2
due, which was subsequently purified by flash column chromatog-mL/100 mg of resin, 1 3 3 min., 2 3 17 min., washings with DMF
raphy on silica gel.(3 3 2 mL), MeOH (2 3 2 mL), DCM (3 3 2 mL)]. N-FMO-
C2AA22OH (3.6 equiv.) and HOAt (3.6 equiv.) were dissolved in General Procedure B: Basic Cleavage: [5w] The appropriate resin was
anhydrous DCM and anhydrous DMF (DCM/DMF, 4:1, 0.062 ) treated with an anhydrous TEA/MeOH/DMF solution (8.5 mL/0.1
under nitrogen. At 0°C, DIC (3.6 equiv.) was added dropwise to mmol, 1:2:2, v/v/v) under nitrogen. The mixture was stirred (mag-
this solution. The resulting mixture was stirred for 10 min at this netic stirring bar) at 50°C (2 cycles, 24 h). After each cycle, the
temperature and for a further 10 min at room temperature, then solution was transferred via a cannula (leaving the beads in the
added to the aforementioned H2AA12O2Wang-Merrifield resin. solid-phase reaction vessel for another cycle) to a flask, and the
This mixture was shaken at room temperature for 2.5 h. The solu- resin was washed twice with anhydrous methanol. Evaporation of
tion was then drained and the resin was rinsed with DMF (3 3 2 the solvents under reduced pressure afforded a residue, which was
mL) and DCM (3 3 2 mL). The success of the coupling was as- subsequently purified by flash chromatography on silica gel.
sessed by performing a TNBS test, which showed that 1 cycle was
sufficient for quantitative coupling in all cases. A 20% piperidine/ Cleavage as Benzyl Amides. 2 General Procedure C: The appropri-
ate resin was treated with TFA/H2O solution (95:5, v/v) (5.2 mL/DMF solution was then used to deprotect the FMOC group (same
procedure as above). Then, HATU (2 equiv.), HOAt (2 equiv.), the 0.1 mmol, 1 3 3 min, 13 2 h, and 3 3 5 min). The solutions were
drained, combined, and concentrated under reduced pressure. Acorresponding N-FMOC2[bicyclic lactam]2OH (1 equiv.), DCM/
DMF (1:3, 2.4 mL/0.1 mmol of amino groups), and 2,4,6-collidine solution of benzylamine (1 equiv.) and 2,4,6-collidine (2 equiv.) in
anhydrous DMF (10 mL/mmol of substrate) was added to the re-(2 equiv.) were successively added and the mixture was shaken for
15 h at room temperature. The solution was drained and the resin sulting residue under nitrogen. At 0°C, HATU (2 equiv.) was added
to this solution and the mixture was stirred for 1 h at 0°C and forwas washed with DMF (3 3 2 mL), MeOH (3 3 2 mL), and DCM
(3 3 2 mL). The unreacted amino groups possibly present were 17 h at room temperature. DCM, acetic acid (4 equiv.), and water
were then added and the aqueous layer was extracted with DCMcapped by treatment with a 0.33  solution of acetylimidazole (10
equiv.) in DCM for 2 h. The solution was drained and the resin (3 times). The combined organic layers were dried with Na2SO4
and concentrated to yield a residue, which was subsequently puri-was washed with DCM (5 3 2 mL). The capping efficiency was
assessed by performing a TNBS test and in the event of incomplete fied by flash column chromatography on silica gel. In the case of
compounds 7a, 7b, 15a, and 15b, after completion of the reactioncapping a second cycle was carried out. After deprotection of the
FMOC group following the usual procedure, N-FMOC2AA32OH the solvents were evaporated without heating and the residue was
purified directly by flash column chromatography without any in-(4 equiv.), HATU (4 equiv.), HOAt (4 equiv.), DCM/DMF (1:3,
4.38 mL/0.1 mmol of amino groups), and 2,4,6-collidine (4 equiv.) itial work-up.
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Tripeptide Mimics J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 2.4222.20 (m, 2 H, CH2),
2.0821.35 (m, 8 H, CH2), 1.95 (s, 3 H, Ac). 2 13C NMR (75 MHz,H2[(5,7)-Bicyclic lactam]2GlyOMe (4a): General Procedure 1 was
CDCl3, 300 K): ä 5 174.5, 172.1, 171.2, 169.9, 136.3, 129.2, 128.6,followed. Cleavage from the resin using the basic method (General
127.0, 60.9, 59.6, 54.1, 53.4, 52.2, 41.0, 38.5, 34.7, 33.3, 31.0, 27.5,Procedure B) led to the isolation of the title compound after purifi-
25.9, 23.2.cation by flash column chromatography on silica gel (DCM/
MeOH, 80:20, Rf 5 0.16). Overall yield 37%. 2 [α]D 5 12.5 (c 5 Ac2Cys(tBu)2[(5,7)-Bicyclic lactam]2Met2NHBn (7a): General
0.4, MeOH). 2 1H NMR (300 MHz, 20 m, CDCl3, 300 K): ä 5 Procedure 3 was followed. Cleavage from the resin was effected
7.64 (br. s, 1 H, CONHCH2CO2Me), 4.78 (d, 1 H, J 5 7.5 Hz, according to General Procedure C, with the modification that a
CHCONH), 4.15 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz, TFA/H2O/EtSMe (95:5:1, v/v/v) solution was used. After the usual
HCHCO2Me), 3.82 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz, work-up, Ph3P (1 equiv.) was added to prevent methionine oxi-
HCHCO2Me), 3.8023.68 (m, 2 H, CHNCO, CHNH2), 3.72 (s, 3 dation and the resulting crude material was purified by flash col-
H, OMe), 2.52 (br. s, 2 H, NH2), 2.3922.15 (m, 2 H, CH2), umn chromatography on silica gel (first DCM and then DCM/
2.0921.38 (m, 8 H, CH2). MeOH, 95:5; Rf 5 0.30 for the latter eluent). Overall yield 29%. 2
[α]D 5 217.7 (c 5 0.6, MeOH). 2 1H NMR (300 MHz, CDCl3, 10H2[(5,6)-Bicyclic lactam]2GlyOMe (4b): General Procedure 1 was
m, 300 K): ä 5 7.49 [d, 1 H, J 5 7.5 Hz, CONHCH(CH2)2SMe],followed. Cleavage from the resin using the basic method (General
7.3827.18 (m, 6 H, aromatic H, NHCOCHNHAc), 6.78 (t, 1 H,Procedure B) led to the isolation of the title compound after purifi-
J 5 7.5 Hz, CONHBn), 6.32 (d, 1 H, J 5 7.5 Hz, NHAc),cation by flash column chromatography on silica gel (DCM/
4.6724.50 [m, 3 H, CHCONHCH(CH2)2SMe, CHNHCOCHN-MeOH, 95:5, Rf 5 0.23). Overall yield 63%. 2 [α]D 5 2104.5 (c 5
HAc, CHNHAc], 4.5024.38 [m, 3 H, CONHCH2Ph,1.1, MeOH). 2 1H NMR (300 MHz, 65 m, CDCl3, 300 K): ä 5
CH(CH2)2SMe], 3.8523.70 (m, 1 H, CHNCO), 2.95 (dd, 1 H, J 57.3527.10 (m, 6 H, aromatic H, CONHCH2CO2Me), 4.42 (d, 1 H,
7.5 Hz, J9 5 15.0 Hz, HCHStBu), 2.80 (dd, 1 H, J 5 7.5 Hz, J9 5J 5 7.5 Hz, CHCONH), 4.08 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz,
15.0 Hz, HCHStBu), 2.6022.40 (m, 2 H, CH2CH2SMe), 2.3021.75HCHCO2Me), 3.97 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz,
(m, 10 H, CH2CH2SMe, CH2), 2.06 (s, 3 H, Ac), 2.02 (s, 3 H, SMe),HCHCO2Me), 3.72 (s, 3 H, OMe), 3.24 (part A of AB system, 1
1.5821.18 (m, 2 H, CH2), 1.32 (s, 9 H, StBu).H, J 5 15.0 Hz, HCHPh), 3.1823.03 (m, 2 H, NH2), 2.79 (part B
of AB system, 1 H, J 5 15.0 Hz, HCHPh), 2.2822.15 (m, 1 H, Ac2Gly2[(5,7)-Bicyclic lactam]2PheOMe (8a): General Pro-
CHNCO), 2.0721.58 (m, 8 H, CH2). 2 13C NMR (50 MHz, cedure 3 was followed. Cleavage from the resin using the acidic
CDCl3, 300 K): ä 5 171.4, 170.3, 136.8, 130.5, 128.0, 126.5, 60.7, method (General Procedure A) led to the isolation of the title com-
59.5, 57.2, 52.2, 45.9, 41.1, 31.5, 29.6, 27.8, 25.9. pound after purification by flash column chromatography on silica
gel (DCM/MeOH, 95:5, Rf 5 0.20). Overall yield 24%. 2 [α]D 5Ac2[(5,6)-Bicyclic lactam]2GlyOMe (5b): General Procedure 2
2 37.5 (c 5 0.40, MeOH). 2 1H NMR (300 MHz, CDCl3, 30 m,was followed. Cleavage from the resin using the acidic method
300 K): ä 5 7.3027.10 (m, 7 H, aromatic H, CONHCHCO2Me,(General Procedure A) led to the isolation of the title compound
NHCOCH2), 6.25 (br. s, 1 H, NHAc), 4.82 (dd, 1 H, J 5 7.5 Hz,after purification by flash column chromatography on silica gel
J9 5 15.0 Hz, CHCO2Me), 4.65 (d, 1 H, J 5 7.5 Hz,(DCM/MeOH, 95:5, Rf 5 0.33). Overall yield 28%. 2 [α]D 5
CHCONHCHBn), 4.40 (dd, 1 H , J 5 7.5 Hz, J9 5 15.0 Hz,275.0 (c 5 0.4, MeOH). 2 1H NMR (300 MHz, CDCl3, 20 m,
CHNHCOCH2), 4.0123.88 (m, 2 H, CH2NHAc), 3.7823.52 (m,300 K): ä 5 7.60 (part X of ABX system, 1 H, J 5 7.5 Hz,
1 H, CHNCO), 3.72 (s, 3 H, OMe), 3.22 (dd, 1 H, J 5 7.5 Hz,CONHCH2CO2Me), 7.3327.16 (m, 5 H, aromatic H), 6.32 (s, 1 H,
J9 5 15.0 Hz, HCHPh), 3.02 (dd, 1 H, J 5 7.5 Hz, J9 5 15.0 Hz,NHAc), 4.41 (d, 1 H, J 5 7.5 Hz, CHCONH), 4.21 (part A of
HCHPh), 2.4022.20 (m, 1 H, CH2), 2.2022.08 (m, 1 H, CH2), 2.05ABX system, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz, HCHCO2Me), 3.72
(s, 3 H, Ac), 1.9021.55 (m, 6 H, CH2), 1.3020.78 (m, 2 H, CH2).(part B of ABX system, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz,
2 13C NMR (50 MHz, CDCl3, 300 K): ä 5 171.9, 170.6, 170.2,HCHCO2Me), 3.70 (s, 3 H, OMe), 3.32 (part A of AB system, 1
167.4, 135.9, 128.9, 128.5, 126.9, 61.3, 59.5, 53.2, 53.1, 52.4, 42.8,H, J 5 15.0 Hz, HCHPh), 2.93 (part B of AB system, 1 H, J 5
37.5, 34.5, 33.1, 30.9, 27.2, 25.9, 22.9.15.0 Hz, HCHPh), 2.5822.48 (m, 1 H, CHNCO), 2.3521.55 (m,
8 H, CH2), 1.90 (s, 3 H, Ac). 2 13C NMR (75 MHz, CDCl3, 300 Ac2Gly2[(5,7)-Bicyclic lactam]2ValOMe (9a): General Procedure
K): ä 5 173.5, 172.5, 170.4, 169.5, 135.5, 130.7, 128.3, 127.5, 60.6, 3 was followed. Cleavage from the resin using the acidic method
59.6, 56.5, 44.5, 41.1, 33.4, 31.1, 28.9, 27.5, 23.6. (General Procedure A) led to the isolation of the title compound
after purification by flash column chromatography on silica gelN-Acetylated Tetrapeptide Mimics
(DCM/MeOH, 95:5, Rf 5 0.25). Overall yield 28%. 2 [α]D 5 22.4Ac2Phe2[(5,7)-Bicyclic lactam]2GlyOMe (6a): General Pro-
(c 5 0.80, MeOH). 2 1H NMR (300 MHz, CDCl3, 20 m, 300cedure 3 was followed, with the modification that DIPEA (8 equiv.)
K): ä 5 7.33 (d, 1 H, J 5 7.5 Hz, NH), 7.28 (d, 1 H, J 5 7.5 Hz,was used for the incorporation of N-FMOC2Phe2OH during 1
NH), 6.25 (br. s, 1 H, NHAc), 4.72 (d, 1 H, J 5 7.5 Hz,coupling cycle. Cleavage from the resin using the acidic method
CHCONHCHiPr), 4.5224.40 (m, 2 H, CHNHCOCH2,(General Procedure B) led to the isolation of the title compound
CHCO2Me), 4.1023.88 (m, 2 H, CH2NHAc), 3.8523.68 (m, 1 H,after purification by flash column chromatography on silica gel
CHNCO), 3.75 (s, 3 H, OMe), 2.4021.60 (m, 9 H, MeCHMe,(DCM/MeOH, 95:5, Rf 5 0.29). Overall yield 9%. 2 [α]D 5 256.7 CH2), 2.02 (s, 3 H, Ac), 1.5321.20 (m, 2 H, CH2), 0.90 (d, 3 H,(c 5 0.6, MeOH). 2 1H NMR (300 MHz, CDCl3, 13 m, 300 K): J 5 7.5 Hz, MeCHMe), 0.88 (d, 3 H, J 5 7.5 Hz, MeCHMe). 2
ä 5 7.3827.05 (m, 7 H, aromatic H, CONHCH2CO2Me, 13C NMR (75 MHz, CDCl3, 300 K): ä 5 172.3, 171.9, 171.0, 61.4,NHCOCHBn), 5.96 (d, 1 H, J 5 7.5 Hz, NHAc), 4.72 (q, 1 H,
59.6, 57.4, 53.3, 52.1, 49.0, 34.9, 33.3, 31.0, 29.6, 27.3, 26.0, 18.9,J 5 7.5 Hz, CHNHAc), 4.7224.60 (m, 1 H, CHCONHCH2- 18.5, 17.6.CO2Me), 4.40 (dd, 1 H, J 5 7.5 Hz, J9 5 6.0 Hz,
CHNHCOCHBn), 4.11 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz, Ac2Phe2[(5,7)-Bicyclic lactam]2Val2NHBn (10a): General Pro-
cedure 3 was followed. Cleavage from the resin according to Gen-HCHCO2Me), 3.81 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz,
HCHCO2Me), 3.8123.68 (m, 1 H, CHNCO), 3.70 (s, 3 H, OMe), eral Procedure C led to the isolation of the title compound after
purification by flash column chromatography on silica gel (DCM/3.10 (dd, 1 H, J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 3.02 (dd, 1 H,
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MeOH, 95:5, Rf 5 0.28). Overall yield 44%. 2 [α]D 5 2 63.2 (c 5 Hz, NHAc), 4.70 (q, 1 H, J 5 7.0 Hz, CHNHAc), 4.40 (d, 1 H,
J 5 7.5 Hz, CHCONHCH2), 4.1023.95 (m, 2 H, CH2CO2Me),0.76, MeOH). 2 1H NMR (300 MHz, CDCl3, 50 m, 300 K): ä 5
7.88 (br. s, 1 H, NHCOCHBn), 7.48 (d, 1 H, J 5 7.5 Hz, CONH- 3.70 (s, 3 H, OMe), 3.15 (part A of AB system, 1 H, J 5 13.0 Hz,
HCHPh), 3.04 (dd, 1 H, J 5 7.0 Hz, J9 5 14.0 Hz, HCHPh), 2.95CHiPr), 7.3827.00 (m, 5 H, aromatic H), 6.64 (t, 1 H, J 5 7.5 Hz,
CONHBn), 6.25 (d, 1 H, J 5 7.5 Hz, NHAc), 4.98 (q, 1 H, J 5 (dd, 1 H, J 5 7.0 Hz, J9 5 14.0 Hz, HCHPh), 2.77 (part B of AB
system, 1 H, J 5 13.0 Hz, HCHPh), 2.4822.32 (m, 1 H, CHNCO),7.0 Hz, CHNHAc), 4.70 (d, 1 H, J 5 7.5 Hz, CHCONHCHiPr),
4.5524.32 (m, 3 H, CHNHCOCHBn, CONHCH2Ph), 4.26 (dd, 1 2.2221.50 (m, 8 H, CH2), 1.99 (s, 3 H, Ac). 2 13C NMR (50 MHz,
CDCl3, 300 K): ä 5 171.5, 171.2, 170.9, 169.6, 136.7, 134.4, 130.6,H, J 5 7.5 Hz, J9 5 8.0 Hz, CHiPr), 3.8723.52 (m, 1 H, CHNCO),
3.00 (dd, 1 H, J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 2.90 (dd, 1 H, 129.2, 128.5, 128.3, 127.5, 126.8, 60.7, 59.7, 58.9, 53.9, 52.1, 44.9,
41.2, 37.2, 33.5, 30.9, 29.0, 27.4, 23.0.J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 2.3022.12 (m, 1 H,
MeCHMe), 2.1222.03 (m, 1 H, CH2), 2.0321.20 (m, 9 H, CH2),
Ac2Cys(tBu)2[(5,6)-Bicyclic lactam]2Met2NHBn (7b): General1.88 (s, 3 H, Ac), 0.9 (d, 3 H, J 5 7.5 Hz, MeCHMe), 0.82 (d, 3
Procedure 3 was followed. Cleavage from the resin was effectedH, J 5 7.5 Hz, MeCHMe). 2 13C NMR (50 MHz, CDCl3, 300
according to General Procedure C, with the modification that aK): ä 5 171.7, 171.5, 170.8, 170.3, 170.1, 138.2, 136.4, 129.0, 128.5,
TFA/H2O/EtSMe (95:5:1, v/v/v) solution was used. After the usual128.3, 127.5, 127.3, 126.9, 61.4, 59.7, 58.7, 53.6, 53.4, 43.2, 39.4,
work-up, Ph3P (1 equiv.) was added to prevent methionine oxi-34.6, 33.2, 31.6, 30.0, 27.4, 26.8, 22.9, 19.6, 17.6.
dation and the resulting crude material was purified by flash col-
Ac2Phe2[(5,7)-Bicyclic lactam]2ValOMe (11a): General Pro- umn chromatography on silica gel (DCM/MeOH, 97:3, Rf 5 0.29).
cedure 3 was followed. Cleavage from the resin using the acidic Overall yield 30%. 2 [α]D 5 280.0 (c 5 0.8, MeOH). 2 1H NMR
method (General Procedure A) led to the isolation of the title com- (300 MHz, CDCl3, 40 m, 300 K): ä 5 7.79 [d, 1 H, J 5 7.5
pound after purification by flash column chromatography on silica Hz, CONHCH(CH2)2SMe], 7.38 (t, 1 H, J 5 7.5 Hz, CONHBn),
gel (DCM/MeOH, 95:5, Rf 5 0.34). Overall yield 40%. 2 [α]D 5 7.3327.12 (m, 10 H, aromatic H), 6.88 (d, 1 H, J 5 7.5 Hz, NHAc),
252.3 (c 5 0.58, MeOH). 2 1H NMR (300 MHz, CDCl3, 50 m, 4.5824.49 [m, 1 H, CH(CH2)SMe], 4.4924.30 [m, 4 H, CHNHAc,
300 K): ä 5 7.65 (br. s, 1 H, NHCOCHBn), 7.38 (d, 1 H, J 5 7.5 CHCONHCH(CH2)2SMe, CONHCH2Ph], 3.22 (d, 1 H, J 5 15.0
Hz, CONHCHiPr), 7.2527.02 (m, 5 H, aromatic H), 6.12 (d, 1 H, Hz, HCHPh), 2.8822.78 (m, 3 H, HCHPh, CH2StBu), 2.5921.73
J 5 7.5 Hz, NHAc), 4.9524.82 (m, 1 H, CHBn), 4.75 (d, 1 H, J 5 (m, 12 H, CH2CH2SMe, CHNCO, CH2), 2.10 (s, 3 H, SMe), 1.92
7.5 Hz, CHCONHCHiPr), 4.5024.40 (m, 2 H, CHNHCOCHBn, (s, 3 H, Ac), 1.5521.41 (m, 1 H, CH2), 1.30 (s, 9 H, StBu). 2 13C
CHCO2Me), 3.8823.72 (m, 1 H, CHNCO), 3.71 (s, 3 H, OMe), NMR (50 MHz, CDCl3, 300 K): ä 5 172.1, 171.3, 171.2, 170.5,
3.05 (dd, 1 H, J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 2.92 (dd, 1 H, 169.4, 138.0, 134.0, 130.7, 128.6, 128.4, 128.1, 127.6, 127.4, 60.9,
J 5 7.5 Hz, J9 5 15.0 Hz, HCHPh), 2.3222.18 (m, 2 H, CH2), 60.0, 58.5, 53.3, 52.4, 45.3, 43.3, 34.9, 31.5, 31.3, 30.9, 30.1, 29.5,
2.1822.05 (m, 1 H, MeCHMe), 2.0521.38 (m, 8 H, CH2), 1.91 (s, 29.0, 27.5, 22.7, 15.4.
3 H, Ac), 0.90 (d, 3 H, J 5 7.5 Hz, MeCHMe), 0.85 (d, 3 H, J 5
7.5 Hz, MeCHMe). 2 13C NMR (75 MHz, CDCl3, 300 K): ä 5 Ac2Ala2[(5,6)-Bicyclic lactam]2ValOMe (12b): General Pro-
172.1, 171.7, 171.1, 170.2, 169.8, 136.3, 129.2, 128.5, 126.9, 61.3, cedure 3 was followed. Cleavage from the resin using the basic
59.7, 57.3, 53.9, 53.5, 52.0, 39.2, 34.8, 33.3, 31.4, 30.9, 27.4, 26.4, method (General Procedure B) led to the isolation of the title com-
23.1, 19.2, 17.7. pound after purification by flash column chromatography on silica
gel (DCM/MeOH, 97:3, Rf 5 0.34). Overall yield 26%. 2 [α]D 5Ac2Ala2[(5,7)-Bicyclic lactam]2ValOMe (12a): General Pro-
2123.6 (c 5 0.5, MeOH). 2 1H NMR (300 MHz, CDCl3, 5 m,cedure 3 was followed. Cleavage from the resin using the acidic
300 K): ä 5 7.3227.11 (m, 8 H, aromatic H, CONHCHiPr,method (General Procedure A) led to the isolation of the title com-
NHCOCHMe, NHAc), 4.6824.50 (m, 1 H, CHNHAc), 4.4524.32pound after purification by flash column chromatography on silica
(m, 2 H, CHCONHCHiPr, CHCO2Me), 3.73 (s, 3 H, OMe), 3.23gel (DCM/MeOH, 95:5, Rf 5 0.20). Overall yield 20%. 2 [α]D 5
(part A of AB system, 1 H, J 5 15.0 Hz, HCHPh), 2.88 (part B285.5 (c 5 0.4, MeOH). 2 1H NMR (300 MHz, CDCl3, 20 m,
of AB system, 1 H, J 5 15.0 Hz, HCHPh), 2.4521.53 (m, 8 H,300 K): ä 5 7.4527.32 (m, 2 H, CONHCHiPr, NHCOCHMe),
CH2, CHNCO), 2.12 (s, 3 H, Ac), 1.5321.32 (m, 1 H, CH2), 1.286.25 (d, 1 H, J 5 7.5 Hz, NHAc), 4.78 (d, 1 H, J 5 7.5 Hz,
(d, 3 H, J 5 7.5 Hz, MeCHNHAc), 1.0420.85 (m, 6 H,CHCONHCHCO2Me), 4.58 (quint, 1 H, J 5 7.5 Hz, CHNHAc),
MeCHMe). 2 13C NMR (75 MHz, CDCl3, 300 K): ä 5 174.5,4.5024.40 (m, 2 H, CHNHCOCHMe, CHCO2Me), 3.8523.68 (m,
173.0, 170.0, 135.5, 130.8, 128.2, 127.4, 60.9, 59.5, 58.0, 51.9, 47.9,1 H, CHNCO), 3.73 (s, 3 H, OMe), 2.3921.70 (m, 9 H, MeCHMe,
45.1, 33.4, 31.3, 30.3, 29.4, 27.5, 23.1, 19.2, 18.9, 16.1.CH2), 2.00 (s, 3 H, Ac), 1.5221.28 (m, 2 H, CH2), 1.35 (d, 3 H,
J 5 7.5 Hz, MeCHNHAc), 1.020.8 (m, 6 H, MeCHMe). 2 13C
Ac2Ala2[(5,6)-Bicyclic lactam]2Val2NHBn (13b): General Pro-NMR (75 MHz, CDCl3, 300 K): ä 5 172.2, 170.7, 170.2, 167.6, cedure 3 was followed. Cleavage from the resin according to Gen-61.4, 59.7, 57.3, 53.4, 52.1, 35.1, 33.4, 31.3, 31.1, 27.4, 25.9, 23.0,
eral Procedure C led to the isolation of the title compound after19.2, 17.7.
purification by flash column chromatography on silica gel (DCM/
MeOH, 97:3, Rf 5 0.30). Overall yield 30%. 2 [α]D 5 260.0 (c 5Ac2Phe2[(5,6)-Bicyclic lactam]2GlyOMe (6b): General Pro-
cedure 3 was followed, with the modification that 2,4,6-collidine (8 0.6, MeOH). 2 1H NMR (300 MHz, CDCl3, 5 m, 300 K): ä 5
7.51 (d, 1 H, J 5 7.5 Hz, CONHCHiPr), 7.3927.15 (m, 12 H,equiv. instead of 4 equiv.) was used for the incorporation of N-
FMOC2Phe2OH during two coupling cycles. Cleavage from the aromatic H, NHCOCHMe, NHAc), 6.92 (t, 1 H, J 5 7.5 Hz,
CONHBn), 4.50 (q, 1 H, J 5 7.5 Hz, NHCOCHMe), 4.4324.30resin using the acidic method (General Procedure A) led to the
isolation of the title compound, together with 5% of another ep- (m, 3 H, CONHCH2Ph, CHCONHCHiPr), 3.97 (t, 1 H, J 5 7.5
Hz, CHiPr), 3.18 (part A of AB system, 1 H, J 5 15.0 Hz,imer, after purification by flash column chromatography on silica
gel (DCM/MeOH, 95:5, Rf 5 0.31). Overall yield 45%. Data for HCHPh), 2.75 (part B of AB system, 1 H, J 5 15.0 Hz, HCHPh),
2.6221.70 (m, 9 H, MeCHMe, CHNCO, CH2), 1.92 (s, 3 H, Ac),the major compound: 2 1H NMR (300 MHz, CDCl3, 50 m, 300
K): ä 5 7.72 (t, 1 H, J 5 6.0 Hz, CONHCH2), 7.3227.10 (m, 10 1.5221.32 (m, 1 H, CH2), 1.31 (d, 3 H, J 5 7.5 Hz, MeCHNHAc),
1.0520.92 (m, 6 H, MeCHMe).H, aromatic H), 7.00 (s, 1 H, NHCOCHBn), 6.61 (d, 1 H, J 5 8.0
Eur. J. Org. Chem. 1999, 3792388386
Solid-Phase Synthesis of Peptides Containing Reverse-Turn Mimetic Bicyclic Lactams FULL PAPER
N-Acetylated Hexapeptide Mimics 171.7, 134.8, 130.7, 128.3, 127.7, 61.0, 60.2, 58.7, 52.6, 47.8, 45.4,
41.5, 34.8, 31.3, 31.1, 29.7, 29.4, 28.5, 27.6, 23.3, 19.7, 17.9, 15.4.
Ac2Val2Ala2[(5,7)-Bicyclic lactam]2Val2GlyOMe (14a): Gen-
Ac2Val2Ala2[(5,6)-Bicyclic lactam]2Val2GlyNHBn (15b): Gen-eral Procedure 4 was followed. Cleavage from the resin using the
eral Procedure 4 was followed. Cleavage from the resin accordingacidic method (General Procedure A) led to the isolation of the
to General Procedure C led to the isolation of the title compoundtitle compound after purification by flash column chromatography
after purification by flash column chromatography on silica gelon silica gel (DCM/MeOH, 95:5, Rf 5 0.14). Overall yield 23%. 2
(DCM/MeOH, 95:5, Rf 5 0.35). Overall yield 45%. 2 [α]D 5[α]D 5 277.3 (c 5 0.4, MeOH). 2 1H NMR (300 MHz, CDCl3,
253.3 (c 5 0.6, MeOH). 2 1H NMR (300 MHz, CDCl3, 40 m,10 m, 300 K): ä 5 7.35 (d, 1 H, J 5 7.5 Hz, NHCOCHMe), 7.25
300 K): ä 5 7.80 (t, 1 H, J 5 7.5 Hz, CONHBn), 7.75 (d, 1 H,(d, 1 H, J 5 7.5 Hz, CONHCHiPr), 6.57 (part X of ABX system,
J 5 7.5 Hz, MeCHNHCO), 7.53 (t, 1 H, J 5 7.5 Hz, CONHCH2),1 H, J 5 7.5 Hz, CONHCH2CO2Me), 6.51 (d, 1 H, J 5 7.5 Hz,
7.45 (s, 1 H, NHCOCHMe), 7.35 (d, 1 H, J 5 7.5 Hz, CONH-NHCOCHiPr), 6.14 (d, 1 H, J 5 9.0 Hz, NHAc), 4.70 (d, 1 H,
CHiPr), 7.3227.03 (m, 10 H, aromatic H), 6.57 (d, 1 H, J 5 7.5J 5 7.5 Hz, CHCONHCHiPr), 4.5824.43 (m, 2 H, NHCOCHMe,
Hz, NHAc), 4.53 (quint, 1 H, J 5 7.5 Hz, NHCOCHMe),CHNHCOCHMe), 4.3524.23 (m, 2 H, CHiPr, CHNHAc), 4.10
4.5324.30 (m, 3 H, CONHCH2Ph, CHCONNCHiPr), 4.21 (t, 1(part A of ABX system, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz,
H, J 5 7.5 Hz, CHNHAc), 4.1823.95 (m, 2 H, HCHCONHBn,HCHCO2Me), 4.00 (part B of ABX system, 1 H, J 5 7.5 Hz, J9 5
CHiPr), 3.78 (dd, 1 H, J 5 7.5 Hz, J9 5 22.5 Hz, HCHCONHBn),22.5 Hz, HCHCO2Me), 3.8823.70 (m, 1 H, CHNCO), 3.75 (s, 3
3.25 (part A of AB system, 1 H, J 5 15.0 Hz, HCHPh), 2.83 (partH, OMe), 2.4022.22 (m, 2 H, MeCHMe, CH2), 2.1221.75 (m, 8
B of AB system, 1 H, J 5 15.0 Hz, HCHPh), 2.4821.88 (m, 7 H,H, MeCHMe, CH2), 2.04 (s, 3 H, Ac), 1.5321.18 (m, 2 H, CH2),
CHNCO, MeCHMe, MeCHMe, CH2), 2.03 (s, 3 H, Ac), 1.8821.621.38 (d, 3 H, J 5 7.5 Hz, NHCOCHMe), 1.0020.88 (m, 12 H,
(m, 2 H, CH2), 1.5021.20 (m, 2 H, CH2), 1.12 (d, 3 H, J 5 7.5MeCHMe, MeCHMe). 2 13C NMR (50 MHz, CDCl3, 300 K):
Hz, NHCOCHMe), 1.0920.92 (m, 12 H, MeCHMe, MeCHMe).ä 5 172.5, 170.9, 170.7, 169.9, 61.8, 59.7, 58.3, 53.4, 52.3, 48.8,
2 13C NMR (75 MHz, CDCl3, 300 K): ä 5 173.3, 172.4, 172.3,41.0, 35.2, 33.4, 31.3, 30.1, 29.6, 27.3, 25.9, 23.2, 19.4, 19.1, 18.6,
171.6, 171.0, 170.3, 138.8, 135.5, 130.8, 128.5, 128.2, 127.5, 127.4,18.1, 17.4.
127.3, 77.2, 61.1, 60.1, 59.5, 47.9, 45.2, 44.4, 43.4, 40.4, 34.8, 31.5,
Ac2Val2Ala2[(5,7)-Bicyclic lactam]2Val2GlyNHBn (15a): Gen- 30.3, 29.1, 28.8, 27.9, 23.2, 19.7, 19.5, 18.2, 15.9.
eral Procedure 4 was followed. Cleavage from the resin according
to General Procedure C led to the isolation of the title compound
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